Yes, pancreatic cancer is on the rise, and the increase is accelerating in some groups faster than others. Overall incidence has been climbing steadily for two decades, and projections indicate that by 2030, pancreatic cancer will be the second deadliest cancer in the United States, behind only lung cancer.
The Sharpest Increases Are in Younger Adults
While pancreatic cancer has historically been a disease of older adults, the most striking trend is how quickly rates are climbing among people under 55. Between 2001 and 2018, the average annual percentage change in incidence for people under 55 was 1.29%. That might sound small, but it compounds year after year, and the younger the age group, the steeper the rise. Among adults aged 25 to 29, incidence increased by an average of 4.34% per year between 1995 and 2014. In the youngest group studied, those aged 15 to 34, the annual increase reached 6.45% in women and 2.97% in men.
For adults 55 and older, the traditional high-risk group, the annual increase was 1.11% with no meaningful difference between men and women. The gap between younger and older groups, and between women and men, is what has researchers paying close attention.
Women Are Seeing Faster Rises Than Men
Across the board, pancreatic cancer incidence is climbing faster in women. Among those under 55, the average annual increase was 2.36% for women compared to 0.62% for men. This pattern isn’t limited to the United States. In the United Kingdom, incidence rates between 1993 and 2018 rose by 208% in females aged 0 to 24 and by 34% in those aged 25 to 49.
Researchers don’t yet have a clear explanation for this sex-based difference. Some suspect it relates to changing patterns of obesity, diabetes, and alcohol use among women over recent decades, but no single factor accounts for the gap.
Obesity and Diabetes Are Fueling the Trend
Two of the strongest risk factors for pancreatic cancer, obesity and type 2 diabetes, have been spreading worldwide at epidemic rates. The relationship between diabetes and pancreatic cancer runs in both directions. Diabetes promotes conditions in the body that favor tumor growth, and people are more likely to develop pancreatic cancer in the first few years after a diabetes diagnosis than later on. At the same time, pancreatic tumors themselves disrupt blood sugar regulation. Fewer than one in ten pancreatic cancer patients have normal fasting blood sugar at the time of diagnosis.
The global rise in obesity and type 2 diabetes, particularly among younger populations, closely mirrors the upward trend in pancreatic cancer cases. This parallel has led researchers to predict that as metabolic conditions continue spreading, pancreatic cancer incidence will follow.
Lifestyle and Gut Health Play a Role
Beyond obesity and diabetes, the recognized risk factors for pancreatic cancer include smoking, heavy alcohol use, family history, and advancing age. What’s newer is the growing understanding of how these exposures interact with the gut microbiome, the community of bacteria living in your digestive tract.
Long-term alcohol consumption, for instance, disrupts the balance of key bacterial groups that are already found at abnormal levels in pancreatic cancer patients. Certain inflammatory bacteria become more abundant, while protective species decline. Physical activity appears to work in the opposite direction, increasing the population of bacteria that produce compounds with anti-inflammatory effects. The practical takeaway is that the same lifestyle habits known to reduce cancer risk generally (staying active, limiting alcohol, maintaining a healthy weight) also promote a gut environment that appears less hospitable to pancreatic cancer development.
Racial Disparities Persist
Black Americans face higher rates of pancreatic cancer than white Americans. Data from Mississippi spanning 2003 to 2019 found that incidence was consistently higher in Black men compared to white men, and in Black women compared to white women, across every region studied. Incidence rates reached as high as 26.91 per 100,000 people in some areas. These disparities reflect a combination of factors including higher rates of obesity and diabetes, differences in healthcare access, and potentially genetic susceptibility, though the exact contributions of each remain under study.
Survival Has Improved, but Remains Low
The five-year survival rate for pancreatic cancer has more than doubled since 2000, rising from about 5.3% to 13.7% based on the most recent federal data covering 2016 through 2022. That improvement reflects genuine progress in surgical techniques, chemotherapy combinations, and earlier detection in some patients. But 13.7% is still among the lowest survival rates of any major cancer, which is why the rising incidence is so concerning. Most pancreatic cancers are caught at an advanced stage, when treatment options are limited.
The combination of increasing case numbers and persistently low survival is what drives the projection that pancreatic cancer will overtake colorectal cancer to become the second leading cause of cancer death by 2030. If current trends in obesity, diabetes, and early-onset diagnosis continue, that timeline could hold or even accelerate.